跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 10,644 条关于
“ENaBL”
全部
10,644
临床试验
558
药物
13
机构
33
资讯
10,040
去年
AstraZeneca Acquires EsoBiotec for $1 Billion: Revolutionary In Vivo CAR-T Technology to Transform Cancer Treatment
去年
AstraZeneca Acquires EsoBiotec for Up to $1 Billion to Transform Cancer Cell Therapy
去年
EsoBiotec's In Vivo BCMA CAR-T Therapy, ESO-T01, Enters Clinical Trials for Multiple Myeloma
去年
Biotech Deal Landscape: February-March 2025 Sees Surge in Partnerships Across Multiple Therapeutic Areas
去年
Cell Therapy and Targeted Therapies Dominate Oncology Advances in Early 2025
10个月前
Incyte Partners with Enable Injections to Develop Subcutaneous Delivery System for First-in-Class mutCALR Therapy
去年
FDA Approves Tremfya for Crohn's Disease and Fabhalta for Rare Kidney Disease Amid Major Pharma Acquisitions
去年
Enable Injections Secures Regulatory Approvals for enFuse Drug Delivery System in Brazil and UK
8个月前
Smart Nanoparticles Enable Disease-Responsive Gene Therapy for Osteoarthritis
上个月
Light-Activated Nanorobots Enable Targeted Phototherapy for Breast Cancer
第 1 页,共 1004 页
上一页
下一页